- Home
- TSAT vs ITOS Comparison
TSAT vs ITOS Comparison
Compare TSAT & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSAT
- ITOS
- Stock Information
- Founded
- TSAT 1969
- ITOS 2011
- Country
- TSAT Canada
- ITOS United States
- Employees
- TSAT N/A
- ITOS N/A
- Industry
- TSAT Metal Fabrications
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TSAT Industrials
- ITOS Health Care
- Exchange
- TSAT Nasdaq
- ITOS Nasdaq
- Market Cap
- TSAT N/A
- ITOS 270.7M
- IPO Year
- TSAT 1996
- ITOS 2020
- Fundamental
- Price
- TSAT $15.77
- ITOS $6.70
- Analyst Decision
- TSAT
- ITOS Strong Buy
- Analyst Count
- TSAT 0
- ITOS 3
- Target Price
- TSAT N/A
- ITOS $25.67
- AVG Volume (30 Days)
- TSAT 79.1K
- ITOS 553.7K
- Earning Date
- TSAT 05-06-2025
- ITOS 04-28-2025
- Dividend Yield
- TSAT N/A
- ITOS N/A
- EPS Growth
- TSAT N/A
- ITOS N/A
- EPS
- TSAT N/A
- ITOS N/A
- Revenue
- TSAT $372,642,710.00
- ITOS $35,000,000.00
- Revenue This Year
- TSAT N/A
- ITOS N/A
- Revenue Next Year
- TSAT N/A
- ITOS $31.74
- P/E Ratio
- TSAT N/A
- ITOS N/A
- Revenue Growth
- TSAT N/A
- ITOS 177.89
- 52 Week Low
- TSAT $7.18
- ITOS $4.80
- 52 Week High
- TSAT $25.38
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- TSAT 43.04
- ITOS 49.45
- Support Level
- TSAT $14.77
- ITOS $6.58
- Resistance Level
- TSAT $17.32
- ITOS $7.80
- Average True Range (ATR)
- TSAT 1.12
- ITOS 0.51
- MACD
- TSAT 0.08
- ITOS -0.03
- Stochastic Oscillator
- TSAT 33.90
- ITOS 32.10
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.